{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Adenocarcinoma of the Uterine Cervix

Activity Steps

Description

NOTE: Individual subscribers will be required to submit payment before viewing. Users accessing via an institutional subscription can proceed without payment.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Compare and contrast cervical adenocarcinoma and squamous cell carcinoma.
  2. Select appropriate diagnostic testing for patients with adenocarcinoma in situ.
  3. Identify the primary treatment strategies for patients with adenocarcinoma in situ and invasive cervical adenocarcinoma.

Learning Outcomes

Seventy-five percent of participants will demonstrate knowledge of cervical adenocarcinoma by achieving a minimum score of 70% on the outcomes-based posttest.
Price: $49.00

Credits:

  • ANCC 2.0 CH
  • DC - BON 2.0 CH
  • FL - BON 2.0 CH
  • GA - BON 2.0 CH
  • NM - BON 2.0 CH
  • SC - BON 2.0 CH
  • WV - BOERN 2.0 CH

Lippincott Professional Development is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.













Test Code: PGO1123A
Published: Nov 2023
Expires: 9/5/2025
Required Passing Score: 7/10 (70%)
Authors: Julia R. Salinaro, MD; Jessica DiSilvestro, MD; Elizabeth Lokich, MD